Virax Biolabs Group Limited
BioCity Glasgow
Bo'Ness Road Newhouse
Lanarkshire, ML1 SUH
United Kingdom
VIA EDGAR
December 29, 2025
U.S. Securities & Exchange Commission
Office of Life Sciences
Division of Corporation Finance
100 F Street, NE
Attn: Jessica Dickerson
|
|
|
|
Re: |
Virax Biolabs Group Limited |
|
|
Registration Statement on Form F-3 |
|
|
Filed December 18, 2025 |
|
|
File No. 333-292241 |
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Virax Biolabs Group Limited hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m., Eastern Time, on December 30, 2025, or as soon as thereafter practicable.
|
|
|
Very truly yours, |
|
|
|
/s/ James Foster |
|
James Foster Chief Executive Officer |
|
|
|